mission statement

mission statement

AACT is a development stage biopharmaceutical company that is developing innovative products for the treatment of cancer.  A key component of AACT’s strategy for eliminating cancer is to exploit the differences in growth regulation between normal and cancer cells and enhance patient’s immune response to cancer through the use of these new drugs.  The Company’s products are small molecule, patent protected drugs that address unmet markets and the three major problems associated with cancer: (i) toxicity, (ii) lack of efficacy and (iii) resistance.